| Brooke Alexa Brooks, PA-C | |
|
3227 Walter Dr Ste 1b, Johns Island, SC 29455-8171 | |
| (843) 872-5454 | |
| Not Available |
| Full Name | Brooke Alexa Brooks |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 3227 Walter Dr Ste 1b, Johns Island, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497398721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MPA.3354PA (South Carolina) | Secondary |
| 363A00000X | Physician Assistant | 3354 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uderitz Family Psychiatry Llc | 8325313851 | 7 |
News Archive
Researchers have found a way to reduce organ rejection following a transplant by using a special polymer to coat blood vessels on the organ to be transplanted.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
Ask Patricia Gibson and she can tell you numerous stories that convey the misconceptions associated with epilepsy. She will tell you about people who have been misdiagnosed and later arrested for their odd behavior following a seizure. She will tell you that she's known people with epilepsy who have been inadvertently hurt by would-be good Samaritans. Most importantly, she will tell you that there are ways to help.
The Los Angeles Times takes a look at how social and religious issues - including abortion and contraception - are fitting in to the current campaign season. Also in the news, how the health law is playing in the North Dakota Senate race and how much money one health care lobbying organization has on hand for campaign contributions.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Alexa Brooks, PA-C 1144 Oakcrest Dr, Charleston, SC 29412-9328 Ph: (610) 751-0374 | Brooke Alexa Brooks, PA-C 3227 Walter Dr Ste 1b, Johns Island, SC 29455-8171 Ph: (843) 872-5454 |
News Archive
Researchers have found a way to reduce organ rejection following a transplant by using a special polymer to coat blood vessels on the organ to be transplanted.
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
Ask Patricia Gibson and she can tell you numerous stories that convey the misconceptions associated with epilepsy. She will tell you about people who have been misdiagnosed and later arrested for their odd behavior following a seizure. She will tell you that she's known people with epilepsy who have been inadvertently hurt by would-be good Samaritans. Most importantly, she will tell you that there are ways to help.
The Los Angeles Times takes a look at how social and religious issues - including abortion and contraception - are fitting in to the current campaign season. Also in the news, how the health law is playing in the North Dakota Senate race and how much money one health care lobbying organization has on hand for campaign contributions.
› Verified 4 days ago